The Mycobiome Frontier – Pre & Post 2020 Status: Integrating Fungal Bioactive Compounds, Probiotics, and Antimicrobial Peptides in Modern Therapeutics and Biotechnology.

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 01 | Page :
    By

    Mukesh Chander*,

  • Tejal Padda 1,

  1. Assistant Professor & Dean Research (Former), P.G., Bioprocess Laboratory, Department of BioTechnology, Khalsa College, Amritsar, Punjab, India
  2. Research Assistant, Bioprocess Laboratory, P.G. Department of Biotechnology, Khalsa College ,Amritsar,, punjab, India

Abstract

The fungal kingdom represents an indispensable resource in modern therapeutics and biotechnology, offering a diverse array of bioactive compounds, probiotics, and antimicrobial peptides (AMPs). Functional fungal polysaccharides (FFPs), such as beta-glucans, chitin, and mannans, are centrally involved in modulating the human gut microbiota, providing novel therapeutic avenues for chronic conditions including diabetes, neurodegenerative disorders, and cancer. These compounds act as prebiotics, nourishing beneficial bacteria and enhancing metabolic parameters such as insulin sensitivity and glucose regulation. Concurrently, fungal probiotics, notably  Saccharomyces boulardii and S. cerevisiae, are gaining recognition for their ability to reestablish eubiosis, enhance gut barrier functions, and modulate immune responses
through the secretion of signaling molecules like short-chain fatty acids (SCFAs). Unlike bacterial counterparts, fungal probiotics are often inherently resistant to antibiotics, making them uniquely valuable for patients undergoing antimicrobial treatment. Furthermore, fungi produce potent antimicrobial peptides and specialized secondary metabolites that have historically defined the golden era of antibiotics and continue to serve as essential candidates for combating multidrug-resistant pathogens. In the sphere of biotechnology, the integration of fungal processes supports a circular bioeconomy through the high-yield production of industrial enzymes, organic acids, pigments, and sustainable mycelium-based materials. This synthesis of fungal applications, ranging from immunosuppressive drugs like cyclosporine to biofuel production,
demonstrates the vast potential for personalizing medicine and promoting environmental sustainability. However, the transition to standard medical practice requires large-scale clinical trials to validate safety and efficacy. This review underscores the role of fungi as sustainable biological factories critical for next-generation therapeutic and industrial innovations.

Keywords: Keywords: Anticancer, Fungal-Gut Biome, Fungal-Probiotics, Mushrooms, Yeast peptides.

How to cite this article:
Mukesh Chander*, Tejal Padda 1. The Mycobiome Frontier – Pre & Post 2020 Status: Integrating Fungal Bioactive Compounds, Probiotics, and Antimicrobial Peptides in Modern Therapeutics and Biotechnology.. International Journal of Fungi. 2026; 03(01):-.
How to cite this URL:
Mukesh Chander*, Tejal Padda 1. The Mycobiome Frontier – Pre & Post 2020 Status: Integrating Fungal Bioactive Compounds, Probiotics, and Antimicrobial Peptides in Modern Therapeutics and Biotechnology.. International Journal of Fungi. 2026; 03(01):-. Available from: https://journals.stmjournals.com/ijf/article=2026/view=239667


References

1. Zhang, Y., Wang, L., & Peng, L. (2025). The Role of Intestinal Fungi in the Pathogenesis and Treatment of Ulcerative Colitis. Microorganisms, 13(4), 794
. https://doi.org/10.3390/ microorganisms13040794
2. Divyashree, S., Shruthi, B., Vanitha, P., & Sreenivasa, M. (2023). Probiotics and their postbiotics for the control of opportunistic fungal pathogens: A review. Biotechnology Reports, 38, e00800. https://doi.org/10.1016/j.btre.2023.e00800
3. Li, M., Yu, L., Zhao, J., Zhang, H., Chen, W., Zhai, Q., & Tian, F. (2021). Role of dietary edible mushrooms in the modulation of gut microbiota. Journal of Functional
Foods, 83, 104538. https://doi.org/10.1016/j.jff.2021.104538
4. Rousta, N., Aslan, M., Yesilcimen Akbas, M., Ozcan, F., Sar, T., & Taherzadeh, M. J. (2024). Effects of fungal-based bioactive compounds on human health: Review paper. Critical Reviews in Food Science and Nutrition, 64(20), 7004–7027. https://doi.org/10.1080/10408398.2023.2178379
5. Chander, M. (2025). Fungal-derived Nutraceuticals & Bioactive Compounds with Physiotherapeutic and Health- promoting Properties: A Comprehensive Review.
International Journal of Fungi, 2 (2), 1-9. https://journals.stmjournals .com/ijf/article =2025/view=228797. https://doi.org/10.37591/IJF.v02i02.228797
6. Barcan, A. S., Barcan, R. A., & Vamanu, E. (2024). Therapeutic Potential of Fungal Polysaccharides in Gut Microbiota Regulation: Implications for Diabetes,
Neurodegeneration and Oncology. Journal of Fungi, 10(6), 394. https://doi.org/10.3390/jof1006039417
7. Hussain, A., Rabbani, N., Areeb, M., & Ali, S.A. (2025). Fungi as Probiotics: Properties and Applications. In book: Fungal Biotechnology Edition: 1. Chapter: 22. Publisher: CRC Press.
8. Törős, G., El-Ramady, H., Prokisch, J., Velasco, F., Llanaj, X., H Nguyen, D. H., & Peles, F. (2023). Modulation of the Gut Microbiota with Prebiotics and Antimicrobial
Agents from Pleurotus ostreatus Mushroom. Foods, 12(10), 2010. https://doi.org/10.3390 /foods 12102010
9. Eberl, A., Saqib, S., Korpela, K., Virtanen, S., Sipponen, T., Salonen, A., Saavalainen, P., & Nissilä, E. (2021). Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 15(6), 1019- 1031. https://doi.org/10.1093/ecco-jcc/jjaa252
10. Chander, M. & Paul, M. (2025). Therapeutic & Diagnostic Applications of Biosurfactants of Microbial Origin. International Journal for Multidisciplinary Research, 7 (1), 1-25. https://doi.org.10.36948/ijfmr.2025. v07i04. 50288
11. Kosgey, J. C., Jia, L., Fang, Y., Yang, J., Gao, L., Wang, J., Nyamao, R., Cheteu, M., Tong, D., Wekesa, V., Vasilyeva, N., & Zhang, F. (2019). Probiotics as antifungal agents: Experimental confirmation and future prospects. Journal of Microbiological Methods, 162, 28-37. https://doi.org/10.1016/j.mimet.2019.05.001
12. Wang, L., Li, M., Liu, C., Li, X., Wang, P., Chang, J., Jin, S., Yin, Q., Zhu, Q., Dang, X., & Lu, F. (2025). Effects of Fungal Probiotics on Rumen Fermentation and Microbiota in Angus Cattle. Animals, 15(18). https://doi.org/10.3390/ani15182746
13. Haifer, C., Paramsothy, S., Kaakoush, N. O., Saikal, A., Ghaly, S., Yang, T., Luu, L. D. W., Borody, T. J., & Leong, R. W. (2022). Lyophilised oral faecal microbiota
transplantation for ulcerative colitis (LOTUS): A randomised, double-blind, placebo- controlled trial. The Lancet Gastroenterology & Hepatology, 7(2), 141-151
. https://doi.org/10.1016/S2468-1253(21)00400-3
14. Kumar, R., Salwan, R., & Chander, M. (2023). The Synthesis of Medicinally Important Pharma Molecules from Carbohydrate Building Blocks. International Journal of Novel Research and Development, 8 (5): e138-148. https://ijnrd.org/viewpaperforall.php?paper= IJNRD2305414
15. Wu, Y., Hu, S., Wu, C., Gu, F., & Yang, Y. (2022). Probiotics: Potential Novel 18 Therapeutics Against Fungal Infections. Frontiers in Cellular and Infection
Microbiology, 11, 793419. https://doi.org/10.3389/fcimb.2021.793419
16. Bulut, S.D., Döndaş, H.A., Celebioglu, H.U. et al. Recent Insights About Probiotics Related Pharmabiotics in Pharmacology: Prevention and Management of
Diseases. Probiotics & Antimicro. Prot. 17, 2262–2292 (2025). https://doi.org/10.1007/s12602-025-10613-3
17. Miguel, U.F. de., Sara, A., Enriqueta, G.G., & Cotter, P. D. (2020). Antifungal Peptides as Therapeutic Agents. Frontiers in Cellular and Infection
Microbiology, 10, 518678. https://doi.org/10.3389/fcimb.2020.00105
18. Abid, R., Waseem, H., Ali, J., Ghazanfar, S., Ali, G. M., Elasbali, A. M., Alharethi, S. H., Abid, R., Waseem, H., Ali, J., Ghazanfar, S., Ali, G. M., Elasbali, A. M., & Alharethi, S. H. (2022). Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. Journal of Fungi, 8(5). https://doi.org/10.3390/jof8050444
19. Corbu, V. M., Gheorghe-Barbu, I., Dumbravă, A. Ș., Vrâncianu, C. O., Șesan, T. E., Corbu, V. M., Gheorghe-Barbu, I., Dumbravă, A. Ș., Vrâncianu, C. O., & Șesan, T.E. (2023) . Current Insights in Fungal Importance: A Comprehensive Review. Microorganisms , 11(6). https://doi.org/10.3390 /microorganisms11061384
20. Neha, B., Samiksha, S., Rashmi, P., Sumit, K. D., Sahil, & Vimal, P. (2024). Role of fungal metabolites in pharmaceuticals, human health, and agriculture, Editor(s): Kamel A. Abd-Elsalam, Heba I. Mohamed, In Nanobiotechnology for Plant Protection, Fungal 2 0 Metabolites, Elsevier, 519-535. https://doi.org/10.1016/B978-0-323-95241-5.00005-8.
21. Sharma, E., Chander, M., & Kaur, K. (2024). Diagnosis Management &  Treatment of Urinary Tract Infections: A Recent Perspective. International Journal of Current
Research Academic Reviews, 12(8), 11-34. https://doi.org/10. 20546/ ijcrar. 2024.1208.002
22. Ferrão, J., Bell, Chaquisse, E., Garrine, C., &  Fernandes, T.H. (2020). The Synbiotic Role of Mushrooms: is Germanium a Bioactive Prebiotic Player? A Review
Article. American Journal of Food and Nutrition, 7, 26-35.
23. Zhang, F., Zuo, T., Yeoh, Y. K., Cheng, F. W., Liu, Q., Tang, W., Cheung, K. C., Yang, K., Cheung, C. P., Mo, C. C., Hui, M., Chan, F. K., Li, C., Chan, P. K., & Ng, S.
C. (2021). Longitudinal dynamics of gut bacteriome, mycobiome, and virome after fecal 19 microbiota transplantation in graft-versus-host disease. Nature Communications, 12 (1), 65. https://doi.org/10.1038/s41467-020-20240-x
24. Chander, M. (2024). Rauwolfia serpentina: A Comprehensive Phytochemical Study of Its Bioactive Metabolites. Emerging Trends in Metabolites, 1(2), 14–40.
https://journals.stmjournals.com/etm/ article=2024/view=170249
25. Leonardi,I., Gao, I.H., Lin, W.Y., Allen, M., Li, X.V., William D., Fiers, Celie,M.B.D., Putzel, G.G., Rhonda K. Y., Johncilla,M., and Colak, D. (2022). Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity. Cell, 185, 831-846. https://doi.org/10.1016/j.cell.2022.01.017
26. Wang, X., Cui, Y., Sang, C., Wang, B., Yuan, Y., Liu, L., Yuan, Y., & Yue, T. (2022). Fungi with potential probiotic properties isolated from Fuzhuan brick
tea. Food Science and Human Wellness, 11(3), 686- 696. https://doi.org/10.1016/j.fshw.2021.12.02
27. Ghosh, K., Harikrishnan, R., Mukhopadhyay, A., Ringø, E., Ghosh, K., Harikrishnan, R., Mukhopadhyay, A., & Ringø, E. (2023). Fungi and Actinobacteria: Alternative Probiotics for Sustainable Aquaculture. Fishes, 8(12). https://doi.org/10.3390/fishes8120575
28. https://asm.org/press-releases/2023/october/fungi-used-in-food-production-could-lead-to- new-pr
29. Chander, M., Kaur, J. 2024. Aquatic Ecosystems: A Review on Prospecting of Anticancer Molecules from Fungi & Other Microbes. International Journal of Fungi.
2024; 1 (2). https://journals.stmjournals.com/ijf/article=2024/view=172169
30. Chen, S., Yi, M., Yi, X., Zhou, Y., Song, H., & Zeng, M. (2025). Unveiling the fungal frontier: Mycological insights into inflammatory bowel disease. Frontiers in
Immunology, 16, 1551289. https://doi.org/10.3389/fimmu.2025.1551289
31. Huang, H., Wang, Q., Yang, Y., Zhong, W., He, F., & Li, J. (2024). The mycobiome as an integral part of the gut microbiome: Crucial role of symbiotic fungi in health and disease. Gut Microbes, 16(1), 2440111. https://doi.org/10.1080/19490976.2024.2440111
32. Jaddaoui, I. E., Sehli, S., Idrissi, N. A., Bakri, Y., Belyamani, L., & Ghazal, H. (2025). The Gut Mycobiome for Precision Medicine. Journal of Fungi, 11 (4)
. https://doi.org/10.3390/jof11040279

Ahead of Print Subscription Review Article
Volume 03
01
Received 28/01/2026
Accepted 06/03/2026
Published 15/03/2026
Publication Time 46 Days
29

Login


My IP

PlumX Metrics